Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
05/10/2023 21:31
Oct 5 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO SELECTS ASCENDIA PHARMACEUTICALS, INC. TO PROVIDE
CDMO
SERVICES TO SUPPORT CLINICAL DEVELOPMENT OF OA-201
Source text for Eikon: ID:nPn2KfR8ma
Further company coverage: AMPE.A
((Reuters.briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank